nonacidic tetrahydroisoquinoline inhibitors of KEAP1/NRF2 (IRBM SpA/CHDI Foundation/Proteros biostructures)

N/A

Report date: 2025/03/20 10:05:29
NME

Base Information

Drug Namenonacidic tetrahydroisoquinoline inhibitors of KEAP1/NRF2 (IRBM SpA/CHDI Foundation/Proteros biostructures)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKelch-like ECH-associated protein 1 inhibitorsNuclear factor erythroid 2-related factor 2 inhibitors
TargetsNuclear factor erythroid 2-related factor 2Kelch-like ECH-associated protein 1
Therapy Area/IndicationsNerve DegenerationHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIrbm SPA
China Registration ClassN/A

Develop Information

Active CompaniesProteros Biostructures GmbHIrbm SPAChdi Foundation Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A